Global RNA Interference (RNAi) Drug Delivery Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global RNA Interference (RNAi) Drug Delivery Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for RNA Interference (RNAi) Drug Delivery by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for RNA Interference (RNAi) Drug Delivery by Country/Region, 2017, 2022 & 2028

2.2 RNA Interference (RNAi) Drug Delivery Segment by Type

2.2.1 Nanoparticle Drug Delivery Technology

2.2.2 Pulmonary Drug Delivery Technology

2.2.3 Nucleic Acid Drug Delivery Technology

2.2.4 Aptamer Drug Delivery Technology

2.3 RNA Interference (RNAi) Drug Delivery Sales by Type

2.3.1 Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Type (2017-2022)

2.3.2 Global RNA Interference (RNAi) Drug Delivery Revenue and Market Share by Type (2017-2022)

2.3.3 Global RNA Interference (RNAi) Drug Delivery Sale Price by Type (2017-2022)

2.4 RNA Interference (RNAi) Drug Delivery Segment by Application

2.4.1 Infectious Diseases

2.4.2 Cardiology

2.4.3 Oncology

2.4.4 Neurology

2.4.5 Ophthalmology

2.4.6 Metabolic Disorders

2.5 RNA Interference (RNAi) Drug Delivery Sales by Application

2.5.1 Global RNA Interference (RNAi) Drug Delivery Sale Market Share by Application (2017-2022)

2.5.2 Global RNA Interference (RNAi) Drug Delivery Revenue and Market Share by Application (2017-2022)

2.5.3 Global RNA Interference (RNAi) Drug Delivery Sale Price by Application (2017-2022)

3 Global RNA Interference (RNAi) Drug Delivery by Company

3.1 Global RNA Interference (RNAi) Drug Delivery Breakdown Data by Company

3.1.1 Global RNA Interference (RNAi) Drug Delivery Annual Sales by Company (2020-2022)

3.1.2 Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Company (2020-2022)

3.2 Global RNA Interference (RNAi) Drug Delivery Annual Revenue by Company (2020-2022)

3.2.1 Global RNA Interference (RNAi) Drug Delivery Revenue by Company (2020-2022)

3.2.2 Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Company (2020-2022)

3.3 Global RNA Interference (RNAi) Drug Delivery Sale Price by Company

3.4 Key Manufacturers RNA Interference (RNAi) Drug Delivery Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers RNA Interference (RNAi) Drug Delivery Product Location Distribution

3.4.2 Players RNA Interference (RNAi) Drug Delivery Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for RNA Interference (RNAi) Drug Delivery by Geographic Region

4.1 World Historic RNA Interference (RNAi) Drug Delivery Market Size by Geographic Region (2017-2022)

4.1.1 Global RNA Interference (RNAi) Drug Delivery Annual Sales by Geographic Region (2017-2022)

4.1.2 Global RNA Interference (RNAi) Drug Delivery Annual Revenue by Geographic Region

4.2 World Historic RNA Interference (RNAi) Drug Delivery Market Size by Country/Region (2017-2022)

4.2.1 Global RNA Interference (RNAi) Drug Delivery Annual Sales by Country/Region (2017-2022)

4.2.2 Global RNA Interference (RNAi) Drug Delivery Annual Revenue by Country/Region

4.3 Americas RNA Interference (RNAi) Drug Delivery Sales Growth

4.4 APAC RNA Interference (RNAi) Drug Delivery Sales Growth

4.5 Europe RNA Interference (RNAi) Drug Delivery Sales Growth

4.6 Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales Growth

5 Americas

5.1 Americas RNA Interference (RNAi) Drug Delivery Sales by Country

5.1.1 Americas RNA Interference (RNAi) Drug Delivery Sales by Country (2017-2022)

5.1.2 Americas RNA Interference (RNAi) Drug Delivery Revenue by Country (2017-2022)

5.2 Americas RNA Interference (RNAi) Drug Delivery Sales by Type

5.3 Americas RNA Interference (RNAi) Drug Delivery Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC RNA Interference (RNAi) Drug Delivery Sales by Region

6.1.1 APAC RNA Interference (RNAi) Drug Delivery Sales by Region (2017-2022)

6.1.2 APAC RNA Interference (RNAi) Drug Delivery Revenue by Region (2017-2022)

6.2 APAC RNA Interference (RNAi) Drug Delivery Sales by Type

6.3 APAC RNA Interference (RNAi) Drug Delivery Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe RNA Interference (RNAi) Drug Delivery by Country

7.1.1 Europe RNA Interference (RNAi) Drug Delivery Sales by Country (2017-2022)

7.1.2 Europe RNA Interference (RNAi) Drug Delivery Revenue by Country (2017-2022)

7.2 Europe RNA Interference (RNAi) Drug Delivery Sales by Type

7.3 Europe RNA Interference (RNAi) Drug Delivery Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa RNA Interference (RNAi) Drug Delivery by Country

8.1.1 Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales by Country (2017-2022)

8.1.2 Middle East & Africa RNA Interference (RNAi) Drug Delivery Revenue by Country (2017-2022)

8.2 Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales by Type

8.3 Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of RNA Interference (RNAi) Drug Delivery

10.3 Manufacturing Process Analysis of RNA Interference (RNAi) Drug Delivery

10.4 Industry Chain Structure of RNA Interference (RNAi) Drug Delivery

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 RNA Interference (RNAi) Drug Delivery Distributors

11.3 RNA Interference (RNAi) Drug Delivery Customer

12 World Forecast Review for RNA Interference (RNAi) Drug Delivery by Geographic Region

12.1 Global RNA Interference (RNAi) Drug Delivery Market Size Forecast by Region

12.1.1 Global RNA Interference (RNAi) Drug Delivery Forecast by Region (2023-2028)

12.1.2 Global RNA Interference (RNAi) Drug Delivery Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global RNA Interference (RNAi) Drug Delivery Forecast by Type

12.7 Global RNA Interference (RNAi) Drug Delivery Forecast by Application

13 Key Players Analysis

13.1 Metabolic disorders

13.1.1 Metabolic disorders Company Information

13.1.2 Metabolic disorders RNA Interference (RNAi) Drug Delivery Product Offered

13.1.3 Metabolic disorders RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Metabolic disorders Main Business Overview

13.1.5 Metabolic disorders Latest Developments

13.2 Alnylam Pharmaceuticals Inc

13.2.1 Alnylam Pharmaceuticals Inc Company Information

13.2.2 Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Offered

13.2.3 Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Alnylam Pharmaceuticals Inc Main Business Overview

13.2.5 Alnylam Pharmaceuticals Inc Latest Developments

13.3 Merck & Co. Inc

13.3.1 Merck & Co. Inc Company Information

13.3.2 Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Product Offered

13.3.3 Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck & Co. Inc Main Business Overview

13.3.5 Merck & Co. Inc Latest Developments

13.4 Access Pharmaceuticals Inc

13.4.1 Access Pharmaceuticals Inc Company Information

13.4.2 Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Offered

13.4.3 Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Access Pharmaceuticals Inc Main Business Overview

13.4.5 Access Pharmaceuticals Inc Latest Developments

13.5 Dicerna Pharmaceuticals Inc

13.5.1 Dicerna Pharmaceuticals Inc Company Information

13.5.2 Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Offered

13.5.3 Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Dicerna Pharmaceuticals Inc Main Business Overview

13.5.5 Dicerna Pharmaceuticals Inc Latest Developments

13.6 Calondo Pharmaceuticals Inc

13.6.1 Calondo Pharmaceuticals Inc Company Information

13.6.2 Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Offered

13.6.3 Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Calondo Pharmaceuticals Inc Main Business Overview

13.6.5 Calondo Pharmaceuticals Inc Latest Developments

13.7 Marina Biotech Inc

13.7.1 Marina Biotech Inc Company Information

13.7.2 Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Product Offered

13.7.3 Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Marina Biotech Inc Main Business Overview

13.7.5 Marina Biotech Inc Latest Developments

13.8 RXi Pharmaceuticals Corp

13.8.1 RXi Pharmaceuticals Corp Company Information

13.8.2 RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Product Offered

13.8.3 RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 RXi Pharmaceuticals Corp Main Business Overview

13.8.5 RXi Pharmaceuticals Corp Latest Developments

13.9 Quark Pharmaceuticals Inc

13.9.1 Quark Pharmaceuticals Inc Company Information

13.9.2 Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Offered

13.9.3 Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Quark Pharmaceuticals Inc Main Business Overview

13.9.5 Quark Pharmaceuticals Inc Latest Developments

13.10 Silence Therapeutics plc

13.10.1 Silence Therapeutics plc Company Information

13.10.2 Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Product Offered

13.10.3 Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Silence Therapeutics plc Main Business Overview

13.10.5 Silence Therapeutics plc Latest Developments

13.11 Tacere Therapeutics Inc

13.11.1 Tacere Therapeutics Inc Company Information

13.11.2 Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Product Offered

13.11.3 Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Tacere Therapeutics Inc Main Business Overview

13.11.5 Tacere Therapeutics Inc Latest Developments

13.12 PhaseRx Inc

13.12.1 PhaseRx Inc Company Information

13.12.2 PhaseRx Inc RNA Interference (RNAi) Drug Delivery Product Offered

13.12.3 PhaseRx Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 PhaseRx Inc Main Business Overview

13.12.5 PhaseRx Inc Latest Developments

13.13 Sirnaomics Inc

13.13.1 Sirnaomics Inc Company Information

13.13.2 Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Product Offered

13.13.3 Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Sirnaomics Inc Main Business Overview

13.13.5 Sirnaomics Inc Latest Developments

13.14 Traversa Therapeutics Inc

13.14.1 Traversa Therapeutics Inc Company Information

13.14.2 Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Product Offered

13.14.3 Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Traversa Therapeutics Inc Main Business Overview

13.14.5 Traversa Therapeutics Inc Latest Developments

14 Research Findings and Conclusion

Table 1. RNA Interference (RNAi) Drug Delivery Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. RNA Interference (RNAi) Drug Delivery Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Nanoparticle Drug Delivery Technology

Table 4. Major Players of Pulmonary Drug Delivery Technology

Table 5. Major Players of Nucleic Acid Drug Delivery Technology

Table 6. Major Players of Aptamer Drug Delivery Technology

Table 7. Global RNA Interference (RNAi) Drug Delivery Sales by Type (2017-2022) & (K Units)

Table 8. Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Type (2017-2022)

Table 9. Global RNA Interference (RNAi) Drug Delivery Revenue by Type (2017-2022) & ($ million)

Table 10. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Type (2017-2022)

Table 11. Global RNA Interference (RNAi) Drug Delivery Sale Price by Type (2017-2022) & (USD/Unit)

Table 12. Global RNA Interference (RNAi) Drug Delivery Sales by Application (2017-2022) & (K Units)

Table 13. Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2017-2022)

Table 14. Global RNA Interference (RNAi) Drug Delivery Revenue by Application (2017-2022)

Table 15. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Application (2017-2022)

Table 16. Global RNA Interference (RNAi) Drug Delivery Sale Price by Application (2017-2022) & (USD/Unit)

Table 17. Global RNA Interference (RNAi) Drug Delivery Sales by Company (2020-2022) & (K Units)

Table 18. Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Company (2020-2022)

Table 19. Global RNA Interference (RNAi) Drug Delivery Revenue by Company (2020-2022) ($ Millions)

Table 20. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Company (2020-2022)

Table 21. Global RNA Interference (RNAi) Drug Delivery Sale Price by Company (2020-2022) & (USD/Unit)

Table 22. Key Manufacturers RNA Interference (RNAi) Drug Delivery Producing Area Distribution and Sales Area

Table 23. Players RNA Interference (RNAi) Drug Delivery Products Offered

Table 24. RNA Interference (RNAi) Drug Delivery Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global RNA Interference (RNAi) Drug Delivery Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global RNA Interference (RNAi) Drug Delivery Sales Market Share Geographic Region (2017-2022)

Table 29. Global RNA Interference (RNAi) Drug Delivery Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global RNA Interference (RNAi) Drug Delivery Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Country/Region (2017-2022)

Table 33. Global RNA Interference (RNAi) Drug Delivery Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas RNA Interference (RNAi) Drug Delivery Sales by Country (2017-2022) & (K Units)

Table 36. Americas RNA Interference (RNAi) Drug Delivery Sales Market Share by Country (2017-2022)

Table 37. Americas RNA Interference (RNAi) Drug Delivery Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas RNA Interference (RNAi) Drug Delivery Revenue Market Share by Country (2017-2022)

Table 39. Americas RNA Interference (RNAi) Drug Delivery Sales by Type (2017-2022) & (K Units)

Table 40. Americas RNA Interference (RNAi) Drug Delivery Sales Market Share by Type (2017-2022)

Table 41. Americas RNA Interference (RNAi) Drug Delivery Sales by Application (2017-2022) & (K Units)

Table 42. Americas RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2017-2022)

Table 43. APAC RNA Interference (RNAi) Drug Delivery Sales by Region (2017-2022) & (K Units)

Table 44. APAC RNA Interference (RNAi) Drug Delivery Sales Market Share by Region (2017-2022)

Table 45. APAC RNA Interference (RNAi) Drug Delivery Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC RNA Interference (RNAi) Drug Delivery Revenue Market Share by Region (2017-2022)

Table 47. APAC RNA Interference (RNAi) Drug Delivery Sales by Type (2017-2022) & (K Units)

Table 48. APAC RNA Interference (RNAi) Drug Delivery Sales Market Share by Type (2017-2022)

Table 49. APAC RNA Interference (RNAi) Drug Delivery Sales by Application (2017-2022) & (K Units)

Table 50. APAC RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2017-2022)

Table 51. Europe RNA Interference (RNAi) Drug Delivery Sales by Country (2017-2022) & (K Units)

Table 52. Europe RNA Interference (RNAi) Drug Delivery Sales Market Share by Country (2017-2022)

Table 53. Europe RNA Interference (RNAi) Drug Delivery Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe RNA Interference (RNAi) Drug Delivery Revenue Market Share by Country (2017-2022)

Table 55. Europe RNA Interference (RNAi) Drug Delivery Sales by Type (2017-2022) & (K Units)

Table 56. Europe RNA Interference (RNAi) Drug Delivery Sales Market Share by Type (2017-2022)

Table 57. Europe RNA Interference (RNAi) Drug Delivery Sales by Application (2017-2022) & (K Units)

Table 58. Europe RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa RNA Interference (RNAi) Drug Delivery Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa RNA Interference (RNAi) Drug Delivery Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of RNA Interference (RNAi) Drug Delivery

Table 68. Key Market Challenges & Risks of RNA Interference (RNAi) Drug Delivery

Table 69. Key Industry Trends of RNA Interference (RNAi) Drug Delivery

Table 70. RNA Interference (RNAi) Drug Delivery Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. RNA Interference (RNAi) Drug Delivery Distributors List

Table 73. RNA Interference (RNAi) Drug Delivery Customer List

Table 74. Global RNA Interference (RNAi) Drug Delivery Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global RNA Interference (RNAi) Drug Delivery Sales Market Forecast by Region

Table 76. Global RNA Interference (RNAi) Drug Delivery Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas RNA Interference (RNAi) Drug Delivery Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas RNA Interference (RNAi) Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC RNA Interference (RNAi) Drug Delivery Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC RNA Interference (RNAi) Drug Delivery Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe RNA Interference (RNAi) Drug Delivery Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe RNA Interference (RNAi) Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa RNA Interference (RNAi) Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global RNA Interference (RNAi) Drug Delivery Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global RNA Interference (RNAi) Drug Delivery Sales Market Share Forecast by Type (2023-2028)

Table 88. Global RNA Interference (RNAi) Drug Delivery Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global RNA Interference (RNAi) Drug Delivery Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global RNA Interference (RNAi) Drug Delivery Sales Market Share Forecast by Application (2023-2028)

Table 92. Global RNA Interference (RNAi) Drug Delivery Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share Forecast by Application (2023-2028)

Table 94. Metabolic disorders Basic Information, RNA Interference (RNAi) Drug Delivery Manufacturing Base, Sales Area and Its Competitors

Table 95. Metabolic disorders RNA Interference (RNAi) Drug Delivery Product Offered

Table 96. Metabolic disorders RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 97. Metabolic disorders Main Business

Table 98. Metabolic disorders Latest Developments

Table 99. Alnylam Pharmaceuticals Inc Basic Information, RNA Interference (RNAi) Drug Delivery Manufacturing Base, Sales Area and Its Competitors

Table 100. Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Offered

Table 101. Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 102. Alnylam Pharmaceuticals Inc Main Business

Table 103. Alnylam Pharmaceuticals Inc Latest Developments

Table 104. Merck & Co. Inc Basic Information, RNA Interference (RNAi) Drug Delivery Manufacturing Base, Sales Area and Its Competitors

Table 105. Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Product Offered

Table 106. Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 107. Merck & Co. Inc Main Business

Table 108. Merck & Co. Inc Latest Developments

Table 109. Access Pharmaceuticals Inc Basic Information, RNA Interference (RNAi) Drug Delivery Manufacturing Base, Sales Area and Its Competitors

Table 110. Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Offered

Table 111. Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 112. Access Pharmaceuticals Inc Main Business

Table 113. Access Pharmaceuticals Inc Latest Developments

Table 114. Dicerna Pharmaceuticals Inc Basic Information, RNA Interference (RNAi) Drug Delivery Manufacturing Base, Sales Area and Its Competitors

Table 115. Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Offered

Table 116. Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 117. Dicerna Pharmaceuticals Inc Main Business

Table 118. Dicerna Pharmaceuticals Inc Latest Developments

Table 119. Calondo Pharmaceuticals Inc Basic Information, RNA Interference (RNAi) Drug Delivery Manufacturing Base, Sales Area and Its Competitors

Table 120. Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Offered

Table 121. Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 122. Calondo Pharmaceuticals Inc Main Business

Table 123. Calondo Pharmaceuticals Inc Latest Developments

Table 124. Marina Biotech Inc Basic Information, RNA Interference (RNAi) Drug Delivery Manufacturing Base, Sales Area and Its Competitors

Table 125. Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Product Offered

Table 126. Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 127. Marina Biotech Inc Main Business

Table 128. Marina Biotech Inc Latest Developments

Table 129. RXi Pharmaceuticals Corp Basic Information, RNA Interference (RNAi) Drug Delivery Manufacturing Base, Sales Area and Its Competitors

Table 130. RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Product Offered

Table 131. RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 132. RXi Pharmaceuticals Corp Main Business

Table 133. RXi Pharmaceuticals Corp Latest Developments

Table 134. Quark Pharmaceuticals Inc Basic Information, RNA Interference (RNAi) Drug Delivery Manufacturing Base, Sales Area and Its Competitors

Table 135. Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Offered

Table 136. Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 137. Quark Pharmaceuticals Inc Main Business

Table 138. Quark Pharmaceuticals Inc Latest Developments

Table 139. Silence Therapeutics plc Basic Information, RNA Interference (RNAi) Drug Delivery Manufacturing Base, Sales Area and Its Competitors

Table 140. Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Product Offered

Table 141. Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 142. Silence Therapeutics plc Main Business

Table 143. Silence Therapeutics plc Latest Developments

Table 144. Tacere Therapeutics Inc Basic Information, RNA Interference (RNAi) Drug Delivery Manufacturing Base, Sales Area and Its Competitors

Table 145. Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Product Offered

Table 146. Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 147. Tacere Therapeutics Inc Main Business

Table 148. Tacere Therapeutics Inc Latest Developments

Table 149. PhaseRx Inc Basic Information, RNA Interference (RNAi) Drug Delivery Manufacturing Base, Sales Area and Its Competitors

Table 150. PhaseRx Inc RNA Interference (RNAi) Drug Delivery Product Offered

Table 151. PhaseRx Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 152. PhaseRx Inc Main Business

Table 153. PhaseRx Inc Latest Developments

Table 154. Sirnaomics Inc Basic Information, RNA Interference (RNAi) Drug Delivery Manufacturing Base, Sales Area and Its Competitors

Table 155. Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Product Offered

Table 156. Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 157. Sirnaomics Inc Main Business

Table 158. Sirnaomics Inc Latest Developments

Table 159. Traversa Therapeutics Inc Basic Information, RNA Interference (RNAi) Drug Delivery Manufacturing Base, Sales Area and Its Competitors

Table 160. Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Product Offered

Table 161. Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 162. Traversa Therapeutics Inc Main Business

Table 163. Traversa Therapeutics Inc Latest Developments

List of Figures

Figure 1. Picture of RNA Interference (RNAi) Drug Delivery

Figure 2. RNA Interference (RNAi) Drug Delivery Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global RNA Interference (RNAi) Drug Delivery Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global RNA Interference (RNAi) Drug Delivery Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. RNA Interference (RNAi) Drug Delivery Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Nanoparticle Drug Delivery Technology

Figure 10. Product Picture of Pulmonary Drug Delivery Technology

Figure 11. Product Picture of Nucleic Acid Drug Delivery Technology

Figure 12. Product Picture of Aptamer Drug Delivery Technology

Figure 13. Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Type in 2021

Figure 14. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Type (2017-2022)

Figure 15. RNA Interference (RNAi) Drug Delivery Consumed in Infectious Diseases

Figure 16. Global RNA Interference (RNAi) Drug Delivery Market: Infectious Diseases (2017-2022) & (K Units)

Figure 17. RNA Interference (RNAi) Drug Delivery Consumed in Cardiology

Figure 18. Global RNA Interference (RNAi) Drug Delivery Market: Cardiology (2017-2022) & (K Units)

Figure 19. RNA Interference (RNAi) Drug Delivery Consumed in Oncology

Figure 20. Global RNA Interference (RNAi) Drug Delivery Market: Oncology (2017-2022) & (K Units)

Figure 21. RNA Interference (RNAi) Drug Delivery Consumed in Neurology

Figure 22. Global RNA Interference (RNAi) Drug Delivery Market: Neurology (2017-2022) & (K Units)

Figure 23. RNA Interference (RNAi) Drug Delivery Consumed in Ophthalmology

Figure 24. Global RNA Interference (RNAi) Drug Delivery Market: Ophthalmology (2017-2022) & (K Units)

Figure 25. RNA Interference (RNAi) Drug Delivery Consumed in Metabolic Disorders

Figure 26. Global RNA Interference (RNAi) Drug Delivery Market: Metabolic Disorders (2017-2022) & (K Units)

Figure 27. Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2017-2022)

Figure 28. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Application in 2021

Figure 29. RNA Interference (RNAi) Drug Delivery Revenue Market by Company in 2021 ($ Million)

Figure 30. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Company in 2021

Figure 31. Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Geographic Region (2017-2022)

Figure 32. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Geographic Region in 2021

Figure 33. Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Region (2017-2022)

Figure 34. Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Country/Region in 2021

Figure 35. Americas RNA Interference (RNAi) Drug Delivery Sales 2017-2022 (K Units)

Figure 36. Americas RNA Interference (RNAi) Drug Delivery Revenue 2017-2022 ($ Millions)

Figure 37. APAC RNA Interference (RNAi) Drug Delivery Sales 2017-2022 (K Units)

Figure 38. APAC RNA Interference (RNAi) Drug Delivery Revenue 2017-2022 ($ Millions)

Figure 39. Europe RNA Interference (RNAi) Drug Delivery Sales 2017-2022 (K Units)

Figure 40. Europe RNA Interference (RNAi) Drug Delivery Revenue 2017-2022 ($ Millions)

Figure 41. Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales 2017-2022 (K Units)

Figure 42. Middle East & Africa RNA Interference (RNAi) Drug Delivery Revenue 2017-2022 ($ Millions)

Figure 43. Americas RNA Interference (RNAi) Drug Delivery Sales Market Share by Country in 2021

Figure 44. Americas RNA Interference (RNAi) Drug Delivery Revenue Market Share by Country in 2021

Figure 45. United States RNA Interference (RNAi) Drug Delivery Revenue Growth 2017-2022 ($ Millions)

Figure 46. Canada RNA Interference (RNAi) Drug Delivery Revenue Growth 2017-2022 ($ Millions)

Figure 47. Mexico RNA Interference (RNAi) Drug Delivery Revenue Growth 2017-2022 ($ Millions)

Figure 48. Brazil RNA Interference (RNAi) Drug Delivery Revenue Growth 2017-2022 ($ Millions)

Figure 49. APAC RNA Interference (RNAi) Drug Delivery Sales Market Share by Region in 2021

Figure 50. APAC RNA Interference (RNAi) Drug Delivery Revenue Market Share by Regions in 2021

Figure 51. China RNA Interference (RNAi) Drug Delivery Revenue Growth 2017-2022 ($ Millions)

Figure 52. Japan RNA Interference (RNAi) Drug Delivery Revenue Growth 2017-2022 ($ Millions)

Figure 53. South Korea RNA Interference (RNAi) Drug Delivery Revenue Growth 2017-2022 ($ Millions)

Figure 54. Southeast Asia RNA Interference (RNAi) Drug Delivery Revenue Growth 2017-2022 ($ Millions)

Figure 55. India RNA Interference (RNAi) Drug Delivery Revenue Growth 2017-2022 ($ Millions)

Figure 56. Australia RNA Interference (RNAi) Drug Delivery Revenue Growth 2017-2022 ($ Millions)

Figure 57. Europe RNA Interference (RNAi) Drug Delivery Sales Market Share by Country in 2021

Figure 58. Europe RNA Interference (RNAi) Drug Delivery Revenue Market Share by Country in 2021

Figure 59. Germany RNA Interference (RNAi) Drug Delivery Revenue Growth 2017-2022 ($ Millions)

Figure 60. France RNA Interference (RNAi) Drug Delivery Revenue Growth 2017-2022 ($ Millions)

Figure 61. UK RNA Interference (RNAi) Drug Delivery Revenue Growth 2017-2022 ($ Millions)

Figure 62. Italy RNA Interference (RNAi) Drug Delivery Revenue Growth 2017-2022 ($ Millions)

Figure 63. Russia RNA Interference (RNAi) Drug Delivery Revenue Growth 2017-2022 ($ Millions)

Figure 64. Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales Market Share by Country in 2021

Figure 65. Middle East & Africa RNA Interference (RNAi) Drug Delivery Revenue Market Share by Country in 2021

Figure 66. Egypt RNA Interference (RNAi) Drug Delivery Revenue Growth 2017-2022 ($ Millions)

Figure 67. South Africa RNA Interference (RNAi) Drug Delivery Revenue Growth 2017-2022 ($ Millions)

Figure 68. Israel RNA Interference (RNAi) Drug Delivery Revenue Growth 2017-2022 ($ Millions)

Figure 69. Turkey RNA Interference (RNAi) Drug Delivery Revenue Growth 2017-2022 ($ Millions)

Figure 70. GCC Country RNA Interference (RNAi) Drug Delivery Revenue Growth 2017-2022 ($ Millions)

Figure 71. Manufacturing Cost Structure Analysis of RNA Interference (RNAi) Drug Delivery in 2021

Figure 72. Manufacturing Process Analysis of RNA Interference (RNAi) Drug Delivery

Figure 73. Industry Chain Structure of RNA Interference (RNAi) Drug Delivery

Figure 74. Channels of Distribution

Figure 75. Distributors Profiles